ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 21.86% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 56.06.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.19%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.19%.
Fairly Valued
The company’s latest PE is 28.41, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 96.52M shares, decreasing 8.11% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 18.68M shares of this stock.